产品介绍
DCC-2036 (Rebastinib),,货号:CC2790,品牌:Chemcatch
DCC-2036 (Rebastinib) is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.
Target:Bcr-Abl
Pathway:Angiogenesis
MW:553.59